the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

US war against Iran costs $11 billion in first week

The US spent over $11.3 billion in the first six days of its war with Iran, a figure that excludes pre-strike buildup costs and is expected to rise substantially.

WASHINGTON: The opening week of the United States’ war against Iran cost more than USD 11.3 billion, according to a Pentagon briefing for lawmakers reported by The New York Times.

This staggering figure, which underscores the rapid consumption of weapons and resources, excludes many costs connected with the military buildup prior to the strikes, suggesting the final tally for the first week could rise substantially.

Defense officials had previously told Congress that roughly USD 5.6 billion worth of munitions were expended in just the first two days of fighting, a burn rate far higher than earlier public estimates.

An independent estimate from the Center for Strategic and International Studies (CSIS) think tank calculated that the first 100 hours of Operation Epic Fury cost USD 3.7 billion, or more than USD 891 million per day.

The CSIS noted that most of these costs, amounting to USD 3.5 billion, had not already been budgeted for by the Pentagon.

Meanwhile, the Iran War Cost Tracker website, which provides real-time estimates, showed a figure of more than USD 17 billion on its counter on Thursday.

According to the site, the United States is currently spending approximately USD 1 billion per day on the conflict.

The tracker also points out that the true long-term cost of the war is likely significantly higher, as such figures do not account for future expenses like veteran healthcare.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings